Diabetes Clinical Trials in Austin

Showing 61-80 of 530 trials

Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

NCT06273124

The purpose of this study is to collect clinical data to support a 7-day wear of the Extended Wear Infusion Set (EWIS). Participants will be asked to: 1. Wear the EWIS for up to 7 consecutive days for 12 consecutive wear periods 2. Perform blood glucose and ketone measurements if continuous glucose meter is ≥250mg/dL for one hour

Type1diabetes

Tandem Diabetes Care, Inc.260 participantsStarted Mar 2024

Newport Beach, California, United States • Stanford, California, United States • Aurora, Colorado, United States +12 more locations

COMPLETEDPhase 3< 1 mile

A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

NCT06045221

The main purpose of this study is to assess efficacy and safety of orforglipron compared with oral semaglutide in participants with Type 2 diabetes and inadequate glycemic control with metformin.The study will last around 61 weeks.

Type 2 Diabetes

Eli Lilly and Company1,698 participantsStarted Sep 2023

Phoenix, Arizona, United States • Canoga Park, California, United States • Escondido, California, United States +128 more locations

Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

Diabetes Trials in Other Cities

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)

Omnipod 5 System Compared to Pump Therapy

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

ALT-801 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus (T2DM)

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

HbA1c Variation Study

T1D Pregnancy & Me

HLA Demographics Study in Adults With Type 1 Diabetes

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients

Other Conditions in Austin